glp 1 receptor agonists in idiopathic intracranial hypertension Novel use of GLP-1 agonist therapy for pediatric hypertension: a case report GLP-1 medications and pseudotumor cerebri
Description
[DOI] [PubMed] [Google Scholar] 56.Payne S, et al
Retatrutide has not been compared head-to-head with earlier GLP-1 medications in any clinical trials, although there is an ongoing trial called TRIUMPH-5, which is comparing it with tirzepatide
Li B, Goss D, Miller JW
Nathanson D, Erdogdu O, Pernow J, Zhang Q, Nystrom T
A randomized phase 2b trial examined the effects of the glucagon-like peptide-1 and glucagon receptor agonist cotadutide on kidney outcomes in patients with diabetic kidney disease
